Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) had its price target lowered by Barclays from $15.00 to $13.00 in a research report sent to investors on Tuesday, The Fly reports. Several other analysts have also commented on SBRA. Truist Financial lowered their price objective on shares of Sabra Health Care REIT from $14.00 to […]
Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) had its target price reduced by Barclays from $15.00 to $13.00 in a research note issued to investors on Tuesday morning, The Fly reports. SBRA has been the topic of a number of other reports. Wells Fargo & Company started coverage on Sabra Health Care REIT in […]
Mesirow Institutional Investment Management Inc. lowered its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Rating) by 18.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 647,710 shares of the real estate investment trust’s stock after selling 144,320 shares during the […]
Credit Suisse Group reissued their neutral rating on shares of Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) in a research report released on Wednesday, Benzinga reports. The firm currently has a $13.00 price target on the real estate investment trust’s stock. Other analysts have also recently issued reports about the stock. Truist Financial reduced […]
Sabra Health Care REIT (NASDAQ:SBRA – Get Rating)‘s stock had its “neutral” rating reissued by investment analysts at Credit Suisse Group in a note issued to investors on Wednesday, Benzinga reports. They currently have a $13.00 target price on the real estate investment trust’s stock. Credit Suisse Group’s price objective suggests a potential upside of […]